58 SYNDECAN-1 Inhibition reverses the pre-malignant phenotype of endometrioma through TGF-BETA signalling: potential implications in endometriosis associated ovarian cancer

Sakthivignesh Ponandai‐Srinivasan, Mario Saare, NR Boggavarapu, S Ehström, PA Garcìa-Uribe, Andres Salumets, Miriam Götte, PG. L. Lalitkumar, Kristina Gemzell‐Danielsson
In: International Journal of Gynecological Cancer · 2019 · vol. 29 , pp. A32 · doi:10.1136/ijgc-2019-igcs.58 · W2974361683
article OA: bronze CC0
📄 Open PDF View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

SYNDECAN-1 inhibition reverses the pre-malignant phenotype of endometrioma by impacting TGF-beta signaling, suggesting a role in endometriosis-associated ovarian cancer.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosisendometrioma

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK